Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,551 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Estimation of ZYKR1 in human urine and plasma utilizing LC-MS/MS positive electrospray ionization; a kappa opioid receptor (KOR) agonist.
Ghoghari A, Bhatt C, Patel K, Jha A, Patel H, Jain M, Momin T, Parmar D, Patel P. Ghoghari A, et al. Among authors: patel h, patel k, patel p. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Nov 15;1185:122982. doi: 10.1016/j.jchromb.2021.122982. Epub 2021 Oct 24. J Chromatogr B Analyt Technol Biomed Life Sci. 2021. PMID: 34731743
A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V).
Pai V, Paneerselvam A, Mukhopadhyay S, Bhansali A, Kamath D, Shankar V, Gambhire D, Jani RH, Joshi S, Patel P. Pai V, et al. Among authors: patel p. J Diabetes Sci Technol. 2014 Jan;8(1):132-141. doi: 10.1177/1932296813518680. Epub 2014 Jan 16. J Diabetes Sci Technol. 2014. PMID: 24876549 Free PMC article.
Lack of inhibition of CYP2C8 by saroglitazar magnesium: In vivo assessment using montelukast, rosiglitazone, pioglitazone, repaglinide and paclitaxel as victim drugs in Wistar rats.
Giri P, Delvadia P, Ladani MK, Prajapati N, Gupta L, Patel N, Joshi V, Giri S, Jain MR, Srinivas NR, Patel PR. Giri P, et al. Among authors: patel n, patel pr. Eur J Pharm Sci. 2019 Mar 15;130:107-113. doi: 10.1016/j.ejps.2019.01.005. Epub 2019 Jan 8. Eur J Pharm Sci. 2019. PMID: 30633968
Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modification.
Zaware P, Shah SR, Pingali H, Makadia P, Thube B, Pola S, Patel D, Priyadarshini P, Suthar D, Shah M, Jamili J, Sairam KV, Giri S, Patel L, Patel H, Sudani H, Patel H, Jain M, Patel P, Bahekar R. Zaware P, et al. Among authors: patel h, patel l, patel p, patel d. Bioorg Med Chem Lett. 2011 Jan 15;21(2):628-32. doi: 10.1016/j.bmcl.2010.12.032. Epub 2010 Dec 10. Bioorg Med Chem Lett. 2011. PMID: 21195611
8,551 results